A case series: thirty-three cases with heterotopic pregnancy after assisted reproductive technology - Scorecard - MDSpire

A case series: thirty-three cases with heterotopic pregnancy after assisted reproductive technology

  • By

  • Xinyang Li

  • Han Zhang

  • Qi Xi

  • Ninglu Yuan

  • Di Su

  • Linlin Liu

  • Zhuo Li

  • Jiayi Tian

  • July 14, 2026

Share

Clinical Scorecard: Analysis of Thirty-Three Cases of Heterotopic Pregnancy Following Assisted Reproductive Techniques

At a Glance

CategoryDetail
ConditionHeterotopic Pregnancy
Key MechanismsInvolves multiple gestational sacs implanted at distinct intrauterine and extrauterine sites, often associated with assisted reproductive technology.
Target PopulationPatients with heterotopic pregnancy diagnosed via assisted reproductive techniques.
Care SettingReproductive Medicine Center, First Hospital of Jilin University

Key Highlights

  • 66.67% of patients achieved viable ongoing intrauterine gestation or live birth.
  • Ultrasonic markers such as fetal cardiac activity significantly predict favorable pregnancy outcomes (OR = 22.00).
  • No significant differences in outcomes between blastocyst and cleavage-stage embryo transfers.
  • Better intrauterine embryonic development correlates with higher odds of favorable outcomes (OR = 28.75).
  • Laparoscopic resection is a common therapeutic strategy for heterotopic pregnancy.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis confirmed by transvaginal sonography or surgical pathological examination.

Management

  • Laparoscopic resection of ectopic gestational lesions is the main therapeutic strategy.

Monitoring & Follow-up

  • Close ultrasound monitoring may allow for conservative management in selected patients.

Risks

  • Risk of rupture of the ectopic lesion is positively correlated with gestational age.

Patient & Prescribing Data

Patients diagnosed with heterotopic pregnancy.

Sequential identification of intrauterine gestational sac and fetal cardiac activity is crucial for predicting outcomes.

Clinical Best Practices

  • Utilize serial plasma human chorionic gonadotrophin (HCG) monitoring for diagnosis.
  • Consider the timing of ultrasound examinations for optimal diagnosis and management.

Related Resources & Content

Original Source(s)

Related Content